Veterinary Parasiticides Market was valued at US $6,373.95 million in 2021 and is projected to grow at 7.08% CAGR over the forecast period to reach US $9,607.69 million by 2027. Veterinary Parasiticides Market represented US $814.84 million opportunity over 2019-2021 and estimated to create US $3,233.74 million opportunity in 2027 over 2021.
Veterinary Parasiticides from Consainsights analyses the Veterinary Parasiticides Market in the Life Sciences industry over the forecast period to 2027.
Veterinary Parasiticides research report from Consainsights outlines the detailed strategic analysis, trends, market opportunities, growth prospects, industry and market challenges and sustainable solutions to sustain in the competitive environment.
Veterinary Parasiticides segmentation includes Product Type, Animal Type and Geography.
Based on the Product Type, the Veterinary Parasiticides analysis covers Ectoparasiticides, Endoparasiticides, Endectocides.
In Product Type segment, Ectoparasiticides segment has highest cagr growth of 6.27%.
Based on the Animal Type, the Veterinary Parasiticides analysis covers Food-Producing Animals, Companion Animals.
In Animal Type segment, Food-Producing Animals segment has highest cagr growth of 6.27%.
Based on the region, the Veterinary Parasiticides analysis covers North America, Europe, Asia-Pacific, Middle-East & Africa, Latin America.
Key companies operating in the market include Bayer AG, Boehringer Ingelheim, ELI Lilly and Company, Merck & Co., Inc., Sanofi, Zoetis, Inc., Ceva Sante Animale, Virbac, Perrigo Company PLC, Vetoquinol S.A. and so on. This report covers the detailed analysis of the company profiles such as business segments, product portfolio, key brand insights and growth strategies adopted, company SWOT and Strategy analysis along with the financial analysis and analyst insights on the key companies operating in this market.